View All Documents & Correspondence
Novel Composition For The Treatment Of Viral Infections
Abstract: The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant for the treatment of Viral infections. The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant specifically for the treatment of COVID-19. The present invention relates to the co-pack of primary active agent and a mucolytic agent as an adjuvant specifically for the treatment of COVID-19. The present invention specifically relates to composition comprising combination of anti-viral agent as primary active agent and a mucolytic agent as an adjuvant for the treatment of COVID-19. The present invention specifically relates composition comprising combination of anti-gout agent as primary active agent and a mucolytic agent as an adjuvant for the treatment of COVID-19. The present invention more specifically relates to the composition comprising Favipiravir as primary active agent and Carbocisteine as adjuvant, Colchicine as primary active agent and Carbocisteine as adjuvant for the treatment of COVID-19.
Notices, Deadlines & Correspondence
Patent Information
Applicants
LYRUS LIFE SCIENCES PVT LTD
NOKHA TRADING LLP
Inventors
1. BOTHRA, Chandanmal Pukhraj
2. BOTHRA, Hemanth Kumar
3. NATARAJAN, Elayaraja
4. AJITHAN VARMA, Chitra
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202247060559.pdf | 2022-10-22 |
| 2 | 202247060559-STATEMENT OF UNDERTAKING (FORM 3) [22-10-2022(online)].pdf | 2022-10-22 |
| 3 | 202247060559-POWER OF AUTHORITY [22-10-2022(online)].pdf | 2022-10-22 |
| 4 | 202247060559-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [22-10-2022(online)].pdf | 2022-10-22 |
| 5 | 202247060559-FORM 18 [22-10-2022(online)].pdf | 2022-10-22 |
| 6 | 202247060559-FORM 1 [22-10-2022(online)].pdf | 2022-10-22 |
| 7 | 202247060559-DECLARATION OF INVENTORSHIP (FORM 5) [22-10-2022(online)].pdf | 2022-10-22 |
| 8 | 202247060559-COMPLETE SPECIFICATION [22-10-2022(online)].pdf | 2022-10-22 |
| 9 | 202247060559-Proof of Right [09-11-2022(online)].pdf | 2022-11-09 |
| 10 | 202247060559-FER.pdf | 2023-01-02 |
| 11 | 202247060559-FORM 3 [18-04-2023(online)].pdf | 2023-04-18 |
| 12 | 202247060559-FORM 4(ii) [23-06-2023(online)].pdf | 2023-06-23 |
| 13 | 202247060559-FER_SER_REPLY [30-09-2023(online)].pdf | 2023-09-30 |
| 14 | 202247060559-CORRESPONDENCE [30-09-2023(online)].pdf | 2023-09-30 |
| 15 | 202247060559-CLAIMS [30-09-2023(online)].pdf | 2023-09-30 |
| 16 | 202247060559-US(14)-HearingNotice-(HearingDate-16-11-2023).pdf | 2023-10-31 |
| 17 | 202247060559-Correspondence to notify the Controller [13-11-2023(online)].pdf | 2023-11-13 |
| 18 | 202247060559-PETITION UNDER RULE 138 [30-11-2023(online)].pdf | 2023-11-30 |
| 19 | 202247060559-Written submissions and relevant documents [21-12-2023(online)].pdf | 2023-12-21 |
| 20 | 202247060559-PatentCertificate21-12-2023.pdf | 2023-12-21 |
| 21 | 202247060559-IntimationOfGrant21-12-2023.pdf | 2023-12-21 |
| 22 | 202247060559-Annexure [21-12-2023(online)].pdf | 2023-12-21 |
Search Strategy
| 1 | searchmerged(1)E_29-12-2022.pdf |
| 2 | SearchHistory(10)AE_31-10-2023.pdf |